Regeneron Pharma exceeds profit expectations in latest quarter.
(Reuters) – Regeneron Pharmaceuticals Inc beats Wall Street estimates for quarterly profit on Thursday, driven by strong demand for eczema treatment Dupixent.
The company reported adjusted profit of $10.24 per share for the second quarter, topping analysts’ average estimates of $9.84, according to Refinitiv data.
(Reporting by Khushi Mandowara in Bengaluru)
The Latest Trump Indictment: Focusing on Mike Pence
President Joe Biden’s Department of Justice indicts Former President Donald J. Trump for a third time with many questioning the timing of it all
A longtime democrat lawmaker from New York who spent 36 years in the assembly said he’s leaving the part for the Republican party.
In the second part of an exclusive interview, Oversight Committee member Representative Andy Biggs tells One America News after witnessing Devon Archer’s closed-door testimony, he is convinced Joe Biden was “taking a cut” of hunter’s business deals.
Apple’s High-Yield Savings Account Surpasses $10 Billion in Customer Deposits
(Reuters) – Apple’s high-yield savings account offered by its partner Goldman Sachs has reached over $10 billion in customer deposits, the technology…
(Reuters) – Apple’s high-yield savings account offered by its partner Goldman Sachs has reached over $10 billion in customer deposits, the technology…
Cognizant Technology Solutions Forecasts Strong Third-Quarter Revenue
(Reuters) – Cognizant Technology Solutions forecast third-quarter revenue above estimates on Wednesday as more businesses turn to the IT services provider to…
(Reuters) – Cognizant Technology Solutions forecast third-quarter revenue above estimates on Wednesday as more businesses turn to the IT services provider to…
" Conservative News Daily does not always share or support the views and opinions expressed here; they are just those of the writer."
*As an Amazon Associate I earn from qualifying purchases
